Insider · CIK 0001559387
Paulus Stoffels
Files at TAK (TAKEDA PHARMACEUTICAL CO LTD). First filing -, latest -.
In brief
Paulus Stoffels files SEC Form 4 as director at TAK (TAKEDA PHARMACEUTICAL CO LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Paulus Stoffels has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Ordinary Shares | +3,800 | $0.00 | $0 | 3,800 | Jul 6, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Tax Obligation Awardderivative | +1,307 | $0.00 | $0 | 1,307 | Jul 6, 2026 |
Questions about Paulus Stoffels
Answered from the filings on this page, as of the latest one.
Is Paulus Stoffels buying or selling?
Paulus Stoffels has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Paulus Stoffels's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paulus Stoffels has 0.
Where does Paulus Stoffels file Form 4?
Paulus Stoffels has filed Form 4 at TAK (TAKEDA PHARMACEUTICAL CO LTD). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.